These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 793103

  • 1. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome.
    Bieber CP, Griepp RB, Oyer PE, Wong J, Stinson EB.
    Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103
    [Abstract] [Full Text] [Related]

  • 2. Radioimmune assay of heterologous serum gamma-globulin in patients receiving rabbit antihuman thymocyte globulin.
    Bieber CP, Lydick E, Griepp RB, David LA, Oyer PE, Stinson EB.
    Transplantation; 1975 Nov; 20(5):393-8. PubMed ID: 54964
    [Abstract] [Full Text] [Related]

  • 3. Cardiac allograft survival in rhesus primates treated with combined total lymphoid irradiation and rabbit antithymocyte globulin.
    Bieber CP, Jamieson S, Raney A, Burton N, Bogarty S, Hoppe R, Kaplan HS, Strober S, Stinson EB.
    Transplantation; 1979 Oct; 28(4):347-50. PubMed ID: 116401
    [Abstract] [Full Text] [Related]

  • 4. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A, Szentpetery S, Mohanakumar T, Barnhart GR, Lower RR.
    J Heart Transplant; 1987 Oct; 6(4):214-7. PubMed ID: 3312532
    [Abstract] [Full Text] [Related]

  • 5. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 6. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar 15; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 7. Effect of rabbit anti-human thymocyte globulin on lymphocyte subpopulations and functions following allotransplantation in the rhesus monkey.
    Thomas JM, Carver M, Scott J, Williams E, Thomas F.
    Transplantation; 1979 Mar 15; 27(3):163-70. PubMed ID: 107631
    [Abstract] [Full Text] [Related]

  • 8. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F, Zieroth S, Rao V, Ross H, Delgado DH.
    J Heart Lung Transplant; 2006 Nov 15; 25(11):1358-62. PubMed ID: 17097501
    [Abstract] [Full Text] [Related]

  • 9. Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis.
    Barlow CW, Moon MR, Green GR, Gamberg P, Theodore J, Reitz BA, Robbins RC.
    Transpl Int; 2001 Aug 15; 14(4):234-9. PubMed ID: 11512056
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 11. Treatment of acute rejection of cadaveric renal allografts with rabbit antithymocyte globulin.
    Hoitsma AJ, Reekers P, Kreeftenberg JG, van Lier HJ, Capel PJ, Koene RA.
    Transplantation; 1982 Jan 27; 33(1):12-6. PubMed ID: 7039017
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr 27; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 13. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG, Icenogle TB, Williams RJ, Rosado LJ, Butman SM, Vasu MA, Sethi GK, McDonald AN, Klees E, Rhenman MJ.
    J Thorac Cardiovasc Surg; 1990 May 27; 99(5):852-60. PubMed ID: 2329823
    [Abstract] [Full Text] [Related]

  • 14. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.
    Transplant Proc; 2014 May 27; 46(6):1928-31. PubMed ID: 25131073
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.
    Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613
    [Abstract] [Full Text] [Related]

  • 16. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH, Mohan P, Little DM, Awan A, Hickey DP.
    J Urol; 2005 Aug 15; 174(2):703-7. PubMed ID: 16006954
    [Abstract] [Full Text] [Related]

  • 17. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
    Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD.
    Ann Surg; 2014 May 15; 259(5):888-93. PubMed ID: 24513787
    [Abstract] [Full Text] [Related]

  • 18. Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
    Hertig A, Zuckermann A.
    Transpl Immunol; 2015 Jun 15; 32(3):179-87. PubMed ID: 25936966
    [Abstract] [Full Text] [Related]

  • 19. Comparative trial of immunoprophylaxis with RATG versus OKT3.
    Griffith BP, Kormos RL, Armitage JM, Dummer JS, Hardesty RL.
    J Heart Transplant; 1990 Jun 15; 9(3 Pt 2):301-5. PubMed ID: 2113093
    [Abstract] [Full Text] [Related]

  • 20. Improved patient and graft survival after treatment of acute rejections of cadaveric renal allografts with rabbit antithymocyte globulin.
    Hoitsma AJ, van Lier HJ, Reekers P, Koene RA.
    Transplantation; 1985 Mar 15; 39(3):274-9. PubMed ID: 3883593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.